These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10391482)

  • 21. Stimulation of adenosine A2A receptors elicits zif/268 and NMDA epsilon2 subunit mRNA expression in cortex and striatum of the "weaver" mutant mouse, a genetic model of nigrostriatal dopamine deficiency.
    Ekonomou A; Poulou PD; Matsokis N; Angelatou F
    Neuroscience; 2004; 123(4):1025-36. PubMed ID: 14751293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondrial toxins in models of neurodegenerative diseases. II: Elevated zif268 transcription and independent temporal regulation of striatal D1 and D2 receptor mRNAs and D1 and D2 receptor-binding sites in C57BL/6 mice during MPTP treatment.
    Smith TS; Trimmer PA; Khan SM; Tinklepaugh DL; Bennett JP
    Brain Res; 1997 Aug; 765(2):189-97. PubMed ID: 9313891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine D1 receptor modulation of glutamate receptor messenger RNA levels in the neocortex and neostriatum of unilaterally 6-hydroxydopamine-lesioned rats.
    Rodríguez-Puertas R; Herrera-Marschitz M; Koistinaho J; Hökfelt T
    Neuroscience; 1999 Mar; 89(3):781-97. PubMed ID: 10199613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Denervation and repeated L-DOPA induce complex regulatory changes in neurochemical phenotypes of striatal neurons: implication of a dopamine D1-dependent mechanism.
    St-Hilaire M; Landry E; Lévesque D; Rouillard C
    Neurobiol Dis; 2005 Nov; 20(2):450-60. PubMed ID: 15896973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat striatum.
    Ichikawa J; Meltzer HY
    Brain Res; 1995 Nov; 698(1-2):204-8. PubMed ID: 8581482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contrasting patterns and cellular specificity of transcriptional regulation of the nuclear receptor nerve growth factor-inducible B by haloperidol and clozapine in the rat forebrain.
    Beaudry G; Langlois MC; Weppe I; Rouillard C; Lévesque D
    J Neurochem; 2000 Oct; 75(4):1694-702. PubMed ID: 10987852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Priming of a D1 dopamine receptor behavioural response is dissociated from striatal immediate-early gene activity.
    Paul ML; Currie RW; Robertson HA
    Neuroscience; 1995 May; 66(2):347-59. PubMed ID: 7477877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonin 5-HT2A receptors underlie increased motor behaviors induced in dopamine-depleted rats by intrastriatal 5-HT2A/2C agonism.
    Bishop C; Tessmer JL; Ullrich T; Rice KC; Walker PD
    J Pharmacol Exp Ther; 2004 Aug; 310(2):687-94. PubMed ID: 15044557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous treatment with the D2 dopamine receptor agonist quinpirole decreases D2 dopamine receptors, D2 dopamine receptor messenger RNA and proenkephalin messenger RNA, and increases mu opioid receptors in mouse striatum.
    Chen JF; Aloyo VJ; Weiss B
    Neuroscience; 1993 Jun; 54(3):669-80. PubMed ID: 8101360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic responses to 5-HT1A or 5-HT2A/2C receptor activation is differentially regulated in four regions of rat brain.
    Tilakaratne N; Friedman E
    Eur J Pharmacol; 1996 Jun; 307(2):211-7. PubMed ID: 8832223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen treatment blocks 8-hydroxy-2-dipropylaminotetralin- and apomorphine-induced disruptions of prepulse inhibition: involvement of dopamine D1 or D2 or serotonin 5-HT1A, 5-HT2A, or 5-HT7 receptors.
    Gogos A; Kwek P; Chavez C; van den Buuse M
    J Pharmacol Exp Ther; 2010 Apr; 333(1):218-27. PubMed ID: 20042529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Striatal gene expression of RGS2 and RGS4 is specifically mediated by dopamine D1 and D2 receptors: clues for RGS2 and RGS4 functions.
    Taymans JM; Leysen JE; Langlois X
    J Neurochem; 2003 Mar; 84(5):1118-27. PubMed ID: 12603835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-stimulation of D(1)/D(5) and D(2) dopamine receptors leads to an increase in c-fos messenger RNA in cholinergic interneurons and a redistribution of c-fos messenger RNA in striatal projection neurons.
    Svenningsson P; Fredholm BB; Bloch B; Le Moine C
    Neuroscience; 2000; 98(4):749-57. PubMed ID: 10891618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Denervation and repeated L-DOPA induce a coordinate expression of the transcription factor NGFI-B in striatal projection pathways in hemi-parkinsonian rats.
    St-Hilaire M; Landry E; Lévesque D; Rouillard C
    Neurobiol Dis; 2003 Oct; 14(1):98-109. PubMed ID: 13678671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of transcription factor genes in striatum by cocaine: role of both serotonin and dopamine systems.
    Bhat RV; Baraban JM
    J Pharmacol Exp Ther; 1993 Oct; 267(1):496-505. PubMed ID: 8229780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity.
    LaHoste GJ; Yu J; Marshall JF
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7451-5. PubMed ID: 8102797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotonin 5-HT2A but not 5-HT2C receptor antagonism reduces hyperlocomotor activity induced in dopamine-depleted rats by striatal administration of the D1 agonist SKF 82958.
    Bishop C; Daut GS; Walker PD
    Neuropharmacology; 2005 Sep; 49(3):350-8. PubMed ID: 15993442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuous or pulsatile chronic D2 dopamine receptor agonist (U91356A) treatment of drug-naive 4-phenyl-1,2,3,6-tetrahydropyridine monkeys differentially regulates brain D1 and D2 receptor expression: in situ hybridization histochemical analysis.
    Goulet M; Morissette M; Calon F; Blanchet PJ; Falardeau P; Bédard PJ; Di Paolo T
    Neuroscience; 1997 Jul; 79(2):497-507. PubMed ID: 9200732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opposite tonic modulation of dopamine and adenosine on c-fos gene expression in striatopallidal neurons.
    Svenningsson P; Fourreau L; Bloch B; Fredholm BB; Gonon F; Le Moine C
    Neuroscience; 1999 Mar; 89(3):827-37. PubMed ID: 10199616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists.
    McPherson RJ; Marshall JF
    Synapse; 2000 Jun; 36(3):194-204. PubMed ID: 10819899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.